Study 200195 App
source

Study 200195 App

Price
Free
Category
Medical
Last update
Feb 21, 2021
Publisher
GlaxoSmithKline PLC Contact publisher
View in store
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Loading...

Description

381 chars

Study 200195 App’s purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis™ (or GSK269273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness). Registry participant’s will be able to use the app to enter the required information for the study.

Screenshots

https://is3-ssl.mzstatic.com/image/thumb/Purple128/v4/99/7d/d5/997dd591-0902-a526-5051-b69b3cf507e6/pr_source.jpg/1242x2208bb.pnghttps://is5-ssl.mzstatic.com/image/thumb/Purple128/v4/ae/de/2c/aede2cb9-6569-13cf-9999-830ea591e921/pr_source.jpg/1242x2208bb.pnghttps://is5-ssl.mzstatic.com/image/thumb/Purple118/v4/19/0a/71/190a714a-6c84-0eba-5669-53d931878114/pr_source.jpg/1242x2208bb.pnghttps://is1-ssl.mzstatic.com/image/thumb/Purple118/v4/78/6b/c9/786bc928-e200-54d7-1c1f-bce15da4f637/pr_source.jpg/1242x2208bb.pnghttps://is2-ssl.mzstatic.com/image/thumb/Purple118/v4/89/bd/f1/89bdf14a-c922-8952-d88d-e27ba68ab953/pr_source.jpg/1242x2208bb.png
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster